U.S. markets closed

Sorrento's Covid-19 Antibody in Question

May.22 -- Sorrento Therapeutics recently said its antibody cocktail has shown 100% inhibition of Covid-19 virus infection, but critics have begun to question its efficacy. Dr. Henry Ji, chairman and chief executive officer at Sorrento Therapeutics, discusses on "Bloomberg Technology."